Eczema (Atopic Dermatitis - Pediatric) Clinical Trials

The purpose of this study is to evaluate the safety and tolerability of topical INCB018424 cream applied to pediatric subjects (≥ 12 to 17 years) with atopic dermatitis (AD).

Wake Research Associates is enrolling volunteers with eczema in a clinical research study testing the effectiveness, tolerability and safety of an investigational medication.

Do you or your child suffer from eczema, also known as atopic dermatitis? Wake Research Associates is enrolling volunteers in a clinical research study testing two, study-related creams to a placebo for individuals with eczema.

This research study will evaluate the effectiveness and safety of two concentrations (0.5 percent [%] and 1%) and two application frequencies (once a day and twice a day) of GSK2894512 cream for the topical treatment in adolescent and adult subjects with atopic dermatitis (eczema). Results from this study will be ...

Do you or your child suffer from Atopic Dermatitis or Eczema?

Severe and/or refractory cases of atopic dermatitis (AD) can require systemic immunosuppressive therapy for disease control, yet there are few studies regarding the appropriate use of these drugs for pediatric AD and even less data comparing them. The current observational study will observe the effect of these therapies on children ...

The current clinical guidelines for management of atopic dermatitis now recommend bleach baths. This requires simply the addition of regular household bleach to twice-weekly baths. At the Mayo Clinic, dilute acetic acid (vinegar) has been recommended for decades in wet wraps to treat patients hospitalized for their atopic dermatitis. However, ...

The purpose of this study is to evaluate the safety, tolerability and the pharmacokinetics (PK) of topical INCB018424 cream applied to pediatric subjects (age 12 to 17 years) with atopic dermatitis (AD).

Objectives To define the cellular and molecular biomarkers of atopic dermatitis in skin biopsies and blood samples from a pre-adolescent pediatric population and correlate it with disease severity. To measure the skin barrier in atopic dermatitis. To determine quality of life in atopic dermatitis through various questionnaires.